AAF-cmk sensitizes tumor cells to trail-mediated apoptosis

Izabela Młnarczuk, Paweł Mróz, Grazyna Hoser, Dominika Nowis, Łukasz P. Biały, Halina Ziemba, Tomasz Grzela, Wojciech Feleszko, Jacek Malejczyk, Cezary Wójcik, Marek Jakóbisiak, Jakub Goła̧b

Research output: Contribution to journalArticlepeer-review

6 Scopus citations


TRAIL is a member of the tumor necrosis factor (TNF) superfamily. This cytokine is cytotoxic for a high proportion of tumor cells, but could be also toxic for normal cells. There is a need to find other agents able to potentiate the antitumor effects of this cytokine. In our study, we found that Ala-Ala-Phe-chloromethylketone (AAF-cmk) augmented cytotoxic activity of TRAIL or TNF against human leukemic cells. Flow cytometry studies and electron microscopy revealed that apoptosis was primarily responsible for this potentiation. Altogether, our studies indicate that AAF-cmk might effectively sensitize human leukemia cells to apoptosis induced by TRAIL and TNF.

Original languageEnglish (US)
Pages (from-to)53-61
Number of pages9
JournalLeukemia Research
Issue number1
StatePublished - Jan 2004


  • AAF-cmk
  • Apoptosis
  • Lymphoma
  • TNF
  • Tripeptidylpeptidase II

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research


Dive into the research topics of 'AAF-cmk sensitizes tumor cells to trail-mediated apoptosis'. Together they form a unique fingerprint.

Cite this